Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Prescription Justice Introduces New 2020 Congressional Report Card on Drug Prices

Report Card Helps Voters Evaluate House and Senate Records Ahead of November Election


News provided by

Prescription Justice

Aug 04, 2020, 08:00 ET

Share this article

Share toX

Share this article

Share toX


SPRINGFIELD, Ill., Aug. 4, 2020 /PRNewswire-PRWeb/ -- Prescription Justice, a non-partisan, nonprofit organization dedicated to lowering drug prices in America, today introduced its new 2020 Congressional report card on drug prices. Using a dynamic, multi-factor methodology, members of the House and Senate are scored and assigned a letter grade, A through F. The grades, which are based on data from votes taken, bills sponsored and co-sponsored, money received by pharmaceutical manufacturers and reviews of policy positions on congressional websites, are accessible at http://www.PrescriptionJustice.org. Congresspersons who take the Prescription Justice Pledge can increase their grades.

The drug prices grade is designed to empower voters, advocacy groups and political organizations to determine who they want to support in upcoming elections based on their records on prescription drug prices. Using the share feature on the web site, grades can easily be shared on Twitter, Facebook, LinkedIn and by email.

Americans deserve to know whether their elected officials are working to solve the problem of drug prices or they are part of the problem, and our new report card will help them find out.

Post this

"High drug prices have long been a public health crisis in our country, and the Covid-19 pandemic has greatly aggravated the problem," said Prescription Justice founder, Gabriel Levitt. "In too many cases, such as with insulin, people are dying because they can't afford common life-saving treatments. Americans deserve to know whether their elected officials are working to solve the problem of drug prices or they are part of the problem, and our new report card will help them find out."

"Most congressional report cards rely on simple vote tallies on a given issue," said Michael Walker, political data analyst at Data Made Useful. "Prescription Justice's report card takes a much deeper dive into analyzing congressional behavior on drug prices. This was in part a matter of necessity, because votes on drug prices are few and far between, but also a matter of substance, because our multidimensional approach can best show voters how committed their elected officials are to this issue."

Unlike most other issues where voters split along ideological lines, Democrats and Republicans agree that prescription drug pricing is a huge problem. Overall, about eighty percent of Americans believe drug prices are unreasonable. Ninety percent of Democrats and 80% of Republican voters want to empower Medicare to negotiate drug prices. The report card reflects the fact that far more Republican members of Congress are out of touch with the electorate, but so are many Congressional Democrats.

In the House of Representatives, there were of 12-As, 210-Bs, 8-Cs, 33-Ds, and 166-Fs. In the Senate there were 15-As, 17-Bs, 14-Cs, 29-Ds, and 24-Fs.

Grade Breakdown by Party in the House and Senate:

-House Democrats: 12-As, 207-Bs, 8-Cs, 3-Ds, 3-Fs
-House Republicans: 0-As, 3-Bs, 0-Cs, 30-Ds, 163-Fs
-Senate Democrats: 14-As, 14-Bs, 7-Cs, 7-Ds, 5-Fs
-Senate Republicans: 1-A, 3-Bs, 7-Cs, 22-Ds, 19-Fs

Total: 27-As, 227-Bs, 22-Cs, 62-Ds, 190-Fs

"Politicians who want to take a stand on drug prices can fill out the Prescription Justice questionnaire. We call it the Prescription Justice Pledge" said Jodi Dart, Executive Director of Prescription Justice. Members of Congress can raise their grades by going on the record on the organization's policy platform. "For each yes answer they give, members are awarded 2 raw score points toward a new or higher grade. Members who entirely commit to the pledge go up a full grade. As a long-time Republican voter, I would like to see members of my party begin to move on this issue and give their voters the relief they need on drug prices."

In addition to the grade which is available at https://prescriptionjustice.org/, Prescription Justice will also offer an online presentation for journalists, members of Congress, advocacy groups and voters to explain how the report card works. For access to the presentation, please contact Jodi Dart. The full press release is also available on the Prescription Justice website, here: https://prescriptionjustice.org/resources/press-releases/press-release-august-4-2020

About Prescription Justice
Prescription Justice, a 501c4 nonprofit organization, is dedicated to ending the crisis of high drug prices in America. Bringing together doctors, lawyers, public health and consumer advocates, and concerned citizens from across party lines, Prescription Justice advocates for serious regulatory and legislative reforms that will substantially lower the cost of prescription drugs for all Americans and expand access to lower-cost medication from abroad. Learn more at: https://www.prescriptionjustice.org/

SOURCE Prescription Justice

Modal title

PJ 2020 Congressional Report Card Press Release
PJ 2020 Congressional Report Card Press Release
PJ 2020 Congressional Report Card Press Release

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.